• University College London
  • United Kingdom
In programme
  • October 23 15:40 to 15:55
  • October 24 15:10 to 15:25
View hours & dates


Meryem Grabski (PhD) is a research associate at the Clinical Psychopharmacology Unit at UCL. Her main research interests are the development of treatments for substance use as well as research on drug use pathways that might ultimately inform policy, for both licit and illicit substances. She is currently working on the ALAMA project as well as KARE, a clinical trial investigating the use ketamine as a possible treatment for alcoholism. She received her PhD on the effect of smoking abstinence on cognitive performance and craving from the University of Bristol in 2017.